Counterfeit forms of weight loss and diabetes drugs are endangering consumers, and Oklahoma General Attorney Gentner Drummond wants to take action against what he calls "bad actors" in the ...

Feb 21 (Reuters) - The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's NOVOb.CO popular weight-loss and diabetes drugs, Wegovy and Ozempic, a ...

As I wrote in my last note on Structure: The most famous examples of GLP-1 agonist drugs are Novo Nordisk's (NVO) semaglutide ... awarded the Nobel Prize for Chemistry in 1976.

The legal battle over who can make and distribute a weight loss ingredient is brewing, and an Edmond telehealth provider is ...

Research peptide providers like Direct Peptides have emerged as trusted sources for compounds like Semaglutide, BPC-157, PT-141, NAD+, and Retatrutide, all clearly labeled for research use only.

It seemed simple enough: She was charged a subscription fee and a fee for the medication she ordered, semaglutide ... whether to authorize payment. Compounds are also generally exempt from ...

The FDA has said there is no longer a shortage in the US market for Novo Nordisk's GLP-1 agonist semaglutide, blocking sales of copycat forms of the drug that have made a lot of money for ...